Search

Displaying results 9561 - 9570 of 10000 in total
  1. Drug

    Zelquistinel

    go.drugbank.com/drugs/DB19336
    Investigational

    Zelquistinel is under investigation in clinical trial NCT06547489 (GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder).

  2. Drug

    Magnesium orotate

    go.drugbank.com/drugs/DB13786
    Experimental

    Experiments investigating the potential cardioprotective actions of orotic acid in pathological heart conditions are still ongoing. … Magnesium orotate is a magnesium salt of orotic acid and is poorly soluble in water. It is a source of magnesium and is used as a mineral supplement to treat Mg deficiency.

  3. Drug

    Inosine 5'-sulfate

    go.drugbank.com/drugs/DB05973
    Experimental

  4. Drug

    Rubitecan

    go.drugbank.com/drugs/DB06159
    Investigational

  5. Drug

    Plevitrexed

    go.drugbank.com/drugs/DB06163
    Investigational

  6. Drug

    INZ-701

    go.drugbank.com/drugs/DB17629
    Investigational

    INZ-701 is an enzyme replacement therapy under development with the intention to be used for the treatment of calcification disorders of the circulatory system, bones, and kidneys.

  7. Drug

    mRNA-3705

    go.drugbank.com/drugs/DB17668
    Investigational

    mRNA-3705 is an investigational mRNA encoding methylmalonic CoA mutase (MUT) enzyme. Developed by Moderna TX Inc., it is being investigated for the treatment of methylmalonic academia.[A258843]

  8. Drug

    Efdoralprin alfa

    go.drugbank.com/drugs/DB18384
    Investigational

    [L54928] It is being investigated as a restorative therapy in adults with AATD emphysema.[L54928]

  9. Drug

    MIP-1095 I-123

    go.drugbank.com/drugs/DB12994
    Experimental

    123 I Mip 1095 is under investigation in clinical trial NCT00712829 (Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents)

  10. Drug

    Mavoglurant

    go.drugbank.com/drugs/DB13004
    Investigational

    Mavoglurant has been used in trials studying the treatment of Patient Diagnosed With OCD and and Resistant to SSRI Treatment (Failed SSRI Over 12 Weeks at Appropriate Doses).